期刊文献+

铁鳌合剂治疗重型地中海贫血铁过载临床研究现状 被引量:5

Clinical Research Status of Iron Chelators in the Treatment of Patients with Severe β-Thalassemia and Iron Overload
下载PDF
导出
摘要 地中海贫血是一类遗传性珠蛋白合成障碍致异常血红蛋白的溶血性贫血。由于基因缺陷和珠蛋白合成障碍程度不一其临床表现严重程度不同,重型地中海贫血是致死性疾病。重型a地中海贫血即Hb Bart’s综合征,常于孕中晚期流产、死胎或生后早期夭折。
作者 刘海燕 于洁
出处 《儿科药学杂志》 CAS 2014年第3期56-60,共5页 Journal of Pediatric Pharmacy
基金 重庆市卫生局医学科学技术研究重点资助项目 项目编号:2010-1-42
  • 相关文献

参考文献6

二级参考文献87

  • 1沈亦逵.重型β地中海贫血的治疗进展[J].实用医学杂志,1995,11(3):184-186. 被引量:4
  • 2方建培,徐宏贵.重型β-地中海贫血的输血和除铁治疗[J].中国小儿血液,2005,10(5):234-235. 被引量:15
  • 3Shalev O,Hileti D,Nortey P,et al.Transport of 14C-deferiprone in normal,thalassaemic and sickle red blood cells.Br J Haematol,1999,105(4):1081-1083
  • 4de Franceschi L,Shalev O,Piga A,et al.Deferiprone therapy in homozygous human beta-thalassemia removes erythrocyte membrane free iron and reduces KCl cotransport activity.J Lab Clin Med,1999,133(1):64-69
  • 5Piga A,Gaglioti C,Fogliacco E,et al.Comparative effects of deferiprone and deferoxamine on survival and cardiac disease in patients with thalassemia major:a retrospective analysis.Hematologica,2003,88(5):489-496
  • 6Olivieri NF,Brittenham GM,McLaren CE,et al.Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia major.N Engl J Med,1998,339(7):417-423
  • 7Tanner MA,Galanello R,Dessi C,et al.A randomized,placebo-controlled,double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia majo rusing cardiovascular magnetic resonance.Circulation,2007,115 (14):1876-1884
  • 8Aydinok Y,Ulger Z,Nart D,et al.A randomized controlled 1-year study of daily deferiprone plus twice weekly desferrioxamine compared with daily deferiprone monotherapy in patients with thalassemia major.Haematologica,2007,92 (12):1599-1606
  • 9Galanello R,Kattamis A,Piga A,et al.A prospective randomized controlled trial on the safety and efficacy of alternating deferoxamine and deferiprone in the treatment of iron overload in patients with thalassemia.Haematologica,2006,91(9):1241-1243
  • 10Ha SY,Chik KW,Ling SC,et al.A randomized controlled study evaluating the safety and efficacy of deferiprone treatment in thalassemia major patients from Hong Kong.Hemoglobin,2006,30(2):263-274

共引文献124

同被引文献77

引证文献5

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部